companydata.dkcompanydata.dk

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS: Financial statements 2019

CVR: 33242840

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS (CVR 33242840) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 26,958,407 and a net result of DKK 1,584,074 compared with DKK 1,376,133 the year before. That is a decrease of 3.1% compared with the year before. Equity in the 2019 report amounted to DKK 6,444,135. The solvency ratio was 63.6%. The company had 34 employees in the financial year.

Gross Profit
DKK 26,958,407
Profit/Loss
DKK 1,584,074
Equity
DKK 6,444,135
Total Assets
DKK 10,128,632
Employees
34

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-27M1.6M6.4M34
2018-27.8M1.4M4.9M29
2017-25.8M1M3.5M32
2016-23.6M1.2M2.5M-
2015-9.6M459K1.3M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS: The 2018 annual report is outJun 30, 2019

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2018. Gross profit came to DKK 27,832,693, and the net result was DKK 1,376,133.

About PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Thomas Noel O´Leary. The board consists of Thomas Noel O´Leary (chair), John Sheahan and Simon Peter Hollywood. The company is owned by ICON CLINICAL (UK) LIMITED. The company has 49 employees (2026). In 2025, the company reported a gross profit of DKK 61,634,124 and a net result of DKK 3,053,580 compared with DKK 3,554,282 the year before. Equity in the 2025 report amounted to DKK 23,945,884.

Source: annual report 2025, Danish Business Authority